A multi-parameter approach for predicting prostate cancer

A multi-parameter approach for predicting prostate cancer

Urokinase plasminogen activator (uPA) and its inhibitor (PAI-1) have shown to be of merit as biomarkers for a variety of cancers. The objective of this project was to assay for uPA and PAI-1 in prostate needle biopsy tissue from 217 patients using the FEMTELLE enzyme linked immunosorbent (ELISA) ass...

Full description

Bibliographic Details
Main Authors:	Antonio Serafin, Angela Chinhengo, Pedro Fernandez, John Akudugu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-01-01
Series:	Cogent Medicine
Subjects:	pai-1 marker prostate biopsies upa marker psa marker prostate cancer benign prostatic hyperplasia transurethral resection of the prostate malignancy index
Online Access:	http://dx.doi.org/10.1080/2331205X.2017.1329257

Similar Items

The potential of PAI-1 expression in needle biopsies as a predictive marker for prostate cancer
by: Antonio Serafin, et al.
Published: (2016-12-01)

Current Indications for Transurethral Resection of the Prostate and Associated Complications
by: Chia-Chu Liu, et al.
Published: (2003-02-01)

Prostate specific antigen levels following transurethral resection of the prostate
by: Roberto C. Fonseca, et al.
Published: (2008-02-01)

Secondary hemorrhage after bipolar transurethral resection and vaporization of prostate
by: Chi-Hang Yee, et al.
Published: (2016-01-01)

Evaluation of outcome of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia: A 10-year experience
by: Hossam Haroun, et al.
Published: (2019-01-01)

Outcome of Surgery for Benign Prostatic Hyperplasia-Is It Predictable?
by: Suhani, et al.
Published: (2013-12-01)

The effect of transurethral prostate resection due to benign prostate hyperplasia on sexual functions
by: Sedat Tastemur, et al.
Published: (2021-09-01)

Comparison of therapeutic effects of green laser enucleation of the prostate and transurethral prostate resection for treatment of benign prostatic hyperplasia
by: WEN Shuang, et al.
Published: (2020-09-01)

Transurethral resection of the prostate stricture management
by: Jian-Wei Wang, et al.
Published: (2020-01-01)

IMPROVING THE QUALITY OF PROSTATE TRANSURETHRAL RESECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA THROUGH INTRAOPERATIVE TRANSRECTAL ULTRASOUND MONITORING OF THE REMOVED TISSUE VOLUME
by: V. B. Filimonov, et al.
Published: (2019-06-01)

Monopolar versus bipolar transurethral resection of prostate for benign prostatic hyperplasia: Operative outcomes and surgeon preferences, a real-world scenario
by: Vijay Kumar Sarma Madduri, et al.
Published: (2016-01-01)

Efficacy of bipolar "button" plasma vaporization of the prostate for benign prostatic obstruction, compared to the standard technique
by: Hamdy Aboutaleb
Published: (2015-01-01)

Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia
by: Yu Xi Terence Law, et al.
Published: (2019-09-01)

Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: A retrospective study at a single academic tertiary care center
by: Yong Wei, et al.

Thulium laser vaporesection (ThuVaRP) versus bipolar transurethral resection of the prostate (TURP) in benign prostate hyperplasia in term of safety and efficacy: A two-year-follow-up study in Erbil, Iraq
by: Wishyar Jamal Al-Bazzaz, et al.
Published: (2020-09-01)

Day care monopolar transurethral resection of prostate: Is it feasible?
by: Altaf Khan
Published: (2014-01-01)

The effect of short-term use of finasteride versus cyproterone acetate on perioperative blood loss with monopolar transurethral resection of prostate
by: Shabieb A. Abdelbaki, et al.
Published: (2021-07-01)

Retrospective analysis of the changes in the surgical treatment of benign prostatic hyperplasia during an 11-year period: a single-center experience
by: Zhu-Feng Peng, et al.
Published: (2021-01-01)

Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis
by: Yu-Li Jiang, et al.
Published: (2019-01-01)

Correlation of benign prostatic obstruction-related complications with clinical outcomes in patients after transurethral resection of the prostate
by: Run-Qi Guo, et al.
Published: (2017-03-01)

DOES HYPOGONADISM ON RESULTS TRANSURETHRAL RESECTION OF BENIGN PROSTATIC HYPERPLASIA?
by: A. V. Sigaev, et al.
Published: (2013-06-01)

A nomogram predicting re-operation due to secondary hemorrhage after monopolar transurethral resection of prostate
by: Run-Qi Guo, et al.
Published: (2018-03-01)

Transurethral microwave thermotherapy for benign prostatic hyperplasia
by: Jonathan N. Rubeinstein, et al.
Published: (2003-06-01)

Acute acalculous cholecystitis after transurethral resection of the prostate
by: Saman Farshid, et al.
Published: (2018-01-01)

Comparing Outcomes of Transurethral Resection of the Prostate in Men with Greater Than or Less Than 100 cc Prostate Volume: A Single-Centre Study
by: Munad Khan, et al.
Published: (2021-06-01)

Suprapubic cystostomy versus nonsuprapubic cystostomy during monopolar transurethral resection of prostate: a propensity score-matched analysis
by: Run-Qi Guo, et al.
Published: (2018-01-01)

Incidence of incidental cancer in transurethral resection of prostate specimens: a 10-year retrospective analysis
by: Döndü Nergiz, et al.
Published: (2021-08-01)

Transurethral plasmakinetic resection of the prostate is a reliable minimal invasive technique for benign prostate hyperplasia: a meta-analysis of randomized controlled trials
by: Kai Wang, et al.
Published: (2015-02-01)

A study on the correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia
by: M C Songra, et al.
Published: (2004-01-01)

Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia
by: Magdy El-Tabey, et al.
Published: (2015-04-01)

Correlation of tools for objective evaluation of infravesical obstruction of men with lower urinary tract symptoms
by: Orestes Mazzariol Jr., et al.

Holmium Laser enucleation of the prostate (HoLEP) versus Transurethral Resection of the Prostate (TURP)
by: Luís Eduardo Durães Barboza, et al.

The efficacy of fibrin glue injection in the prostatic fossa on decreasing postoperative bleeding following transurethral resection of prostate
by: Mohammad Hatef Khorrami, et al.
Published: (2016-01-01)

A prospective study to compare changes in male sexual function following holmium laser enucleation of prostate versus transurethral resection of prostate
by: Praveen Pushkar, et al.
Published: (2019-01-01)

Analysis of Present Status for Surgery of Benign Prostatic Hyperplasia in Korea Using Nationwide Healthcare System Data
by: Byeong Jo Jeon, et al.
Published: (2019-03-01)

Assessment of posterior urethra in benign prostatic hyperplasia and after its surgery
by: Vivek Agrawal, et al.
Published: (2020-01-01)

Predicting Significance of Blood Parameters in Diagnosis of Prostate Carcinoma in a Tertiary Centre in Udaipur, Rajasthan
by: Gulshan Kumar Mukhiya, et al.
Published: (2021-04-01)

Comparison of transurethral plasmakinetic and transvesical prostatectomy in treatment of 100–149 mL benign prostatic hyperplasia
by: Zhi Long, et al.
Published: (2014-04-01)

Is Routine Measurement of Post-operative Hemoglobin and Electrolytes Necessary in Every Patient After Transurethral Resection of the Prostate?
by: Muhammad Hammad Ali Mithani, et al.
Published: (2018-12-01)

Clinical and Pathological Characteristics of Hard Nodules Resistant to Morcellation During Holmium Laser Enucleation of the Prostate
by: Songzhe Piao, et al.
Published: (2015-06-01)